tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Parkes, 2 are a BUY (50%), 1 are a HOLD (25%), 1 are a SELL (25%).
Analyst Richard Parkes, currently employed at BNP, carries an average stock price target met ratio of 50% that have a potential upside of 2.56% achieved within 38 days.
Richard Parkes’s has documented 8 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 27-Jun-2022.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 6/27/2022. The price target of $52.88 was fulfilled within 37 days with a profit of $2.85 (5.11%) receiving and performance score of 1.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$87
$19.43 (28.76%)
$78
5 months 23 days ago
(17-Nov-2024)
8/9 (88.89%)
$23.61 (37.25%)
588
Buy
$88
$20.43 (30.24%)
$82
5 months 28 days ago
(12-Nov-2024)
4/5 (80%)
$22.71 (34.78%)
297
Buy
$95
$27.43 (40.59%)
$66
8 months 29 days ago
(12-Aug-2024)
6/7 (85.71%)
$12.48 (15.12%)
382
Buy
$85
$17.43 (25.80%)
$80
11 months 11 days ago
(30-May-2024)
4/4 (100%)
$8.7 (11.40%)
391
Buy
$84
$16.43 (24.32%)
$85
1 years 19 days ago
(22-Apr-2024)
2/12 (16.67%)
$14.3 (20.52%)
163
What Year was the first public recommendation made by Richard Parkes?
